Originating from the study of differential expression in metastatic and nonmetastatic CRC cell lines, PAPSS2 was identified as a new molecular clone of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthetase 31. This evidence concerns the gene PAPSS2 and colorectal carcinoma.